{
  "kind": "framework",
  "value": "target-product-profile",
  "collectionKey": "slides:framework:target-product-profile:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 6,
  "page": 1,
  "pageSize": 24,
  "pageCount": 1,
  "rows": [
    {
      "docId": "019de076-9b15-737c-b05c-8347f7a98ad7",
      "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6",
      "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides",
      "authorId": "enochian-biosciences",
      "authorName": "Renovaro Biosciences",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "other",
      "function": "present_solution",
      "notes": "This is a standard TPP (Target Product Profile) table used in biotech/pharma pitch decks.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "Standard industry framework for defining clinical development goals",
      "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/24",
      "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7",
      "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 28,
          "from": 5,
          "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.",
          "position": 2,
          "confidence": 0.9,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-4aec-72cf-a6e0-519f4b0af11c",
      "docSlug": "80e6ab6db3df4d91b63f99a2a4cf6dc3",
      "documentTitle": "Exscientia | Investor Presentation Deck | 73 slides",
      "authorId": "exscientia",
      "authorName": "Exscientia",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-07-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 39,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a three-column layout to define the target product profile (TPP) requirements for a CDK7 inhibitor.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "The slide explicitly defines the requirements for a drug candidate's profile.",
      "slideHref": "/slides/019de075-4aec-72cf-a6e0-519f4b0af11c/39",
      "deckHref": "/decks/019de075-4aec-72cf-a6e0-519f4b0af11c",
      "deckAnchorHref": "/decks/019de075-4aec-72cf-a6e0-519f4b0af11c#slide-39",
      "loopMatches": [
        {
          "to": 73,
          "from": 5,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "02ebf716-8af1-4eca-8937-1321b5d2471c",
          "evidence": "The deck presents the consequences of not adopting Exscientia's technology throughout the presentation",
          "position": 0,
          "objective": "What is the cost of not adopting Exscientia's AI-driven precision medicine platform?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.8,
          "description": "Quantify what happens if the audience does nothing"
        },
        {
          "to": 72,
          "from": 29,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "c1ff2e13-046f-4a68-9f90-d544bd3e6de9",
          "evidence": "The deck presents information on Exscientia's clinical stage compounds and their potential benefits",
          "position": 1,
          "objective": "What are the potential benefits of Exscientia's clinical stage compounds?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.7,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de071-805e-75da-a9c3-e9573cb6e94f",
      "docSlug": "f179c2894ff7ef65a3c6d24dd4bec442",
      "documentTitle": "Exscientia | IPO Presentation Deck | 60 slides",
      "authorId": "exscientia",
      "authorName": "Exscientia",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2021-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7893755,
      "pageNumber": 27,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a three-column structure to define the target product profile (TPP) for a drug candidate.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "The slide explicitly defines the requirements for a drug candidate's profile.",
      "slideHref": "/slides/019de071-805e-75da-a9c3-e9573cb6e94f/27",
      "deckHref": "/decks/019de071-805e-75da-a9c3-e9573cb6e94f",
      "deckAnchorHref": "/decks/019de071-805e-75da-a9c3-e9573cb6e94f#slide-27",
      "loopMatches": [
        {
          "to": 60,
          "from": 4,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "3b6b60bf-18b7-4458-bffa-eba1b1ca0583",
          "evidence": "The deck presents a comprehensive loop on the golden circle of problem-solution-benefit.",
          "position": 1,
          "objective": "Explain how Exscientia's AI-driven platform can solve the problem of inefficient drug discovery.",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 60,
          "from": 4,
          "beatId": "5dda98c6-c560-4b21-aa1c-95b617a27a20",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The deck presents a comprehensive solution throughout pages 4-60.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2",
      "docSlug": "9cc11288f450409d9a3eef75fc694943",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a list format to define the TPP, which is a standard pharmaceutical industry framework.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "Standard pharmaceutical development framework for defining drug characteristics",
      "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/27",
      "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2",
      "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b7ca-70fb-95b8-5a74e3aefffe",
      "docSlug": "5062b9a9257606648ea145bccd66e04d",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 41 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 38,
      "slideType": "product_demo",
      "function": "present_solution",
      "notes": "The slide uses a 'Target Product Profile' framework to summarize the drug's key characteristics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "Explicitly labeled as 'Target Product Profile' in the slide content.",
      "slideHref": "/slides/019de076-b7ca-70fb-95b8-5a74e3aefffe/38",
      "deckHref": "/decks/019de076-b7ca-70fb-95b8-5a74e3aefffe",
      "deckAnchorHref": "/decks/019de076-b7ca-70fb-95b8-5a74e3aefffe#slide-38",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-6120-7265-9083-1f4de3ff0bf7",
      "docSlug": "b6cd6d5e2a349d701bc6db22946ed621",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 46,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a Target Product Profile (TPP) framework to define the drug's clinical value proposition.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "Explicitly labeled as 'TARGET PRODUCT PROFILE' with key clinical attributes listed.",
      "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/46",
      "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7",
      "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-46",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}